Olivella-Cirici, M, Garcia-Continente, X, Checa, MB, Cano, GS, Albarracin, GP. The problematic use of the mobile phone: cross-sectional analysis of the individual profile and associated factors. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:. IF:0.900(Q4/9D).

Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De la Fuente-Meira, S, Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Banuls, J, Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2023; 39(5)DOI:10.1111/phpp.12878. PMID:37130164. IF:2.500(Q2/4D).

Gamez, J, Calopa, M, Munoz, E, Ferre, A, Huertas, O, McAllister, K, Reig, N, Scart-Gres, C, Insa, R, Kulisevsky, J. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2023; 89(5)DOI:10.1111/bcp.15635. PMID:36494329. IF:3.100(Q2/4D).

Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Labandeira-Garcia, JL, Lanciego, JL, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Rodriguez-Antiguedad, J. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2023; 110DOI:10.1016/j.parkreldis.2023.105367. PMID:36963339. IF:3.100(Q2/4D).